DAWNE RONALD: Open Payments
NPI 1467193946 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 62 payments from 9 companies in 2025. Trend: 2023 $428 · 2024 $785 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $404 |
| Vanda Pharmaceuticals Inc. | 12 | $215 |
| Alkermes, Inc. | 5 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Almatica Pharma LLC | 3 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, FANAPT, ARISTADA, CAPLYTA, HETLIOZ, AUSTEDO XR, LOREEV XR, REXULTI.
Industry payments across PA — which companies pay providers there.
